MetaCap

Axonex AI Group (AXNX) vs OLB Group (OLB)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Axonex AI Group is the larger company by market cap ($5.3 million vs $3.6 million), about 1.5 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

AXNX+16.92%OLB-77.46%
+66%-9%-84%
Oct 13, 20261 yearNov 20, 2026
AXNX+76.17%OLB-74.16%
+137%+26%-84%
Oct 12, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

AXNX versus OLB key metrics
MetricAXNXOLB
Share price$0.8301$0.115
Market cap$5.28M$3.59M
1-day change-8.28%-4.33%
YTD return—-81.43%
1-year return—-88.14%
5-year return—-99.74%
EPS (TTM)$-10.37$-0.25
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)—$8.68M
Revenue growth (YoY)—-32.42%
Net income (latest FY)$-10.31M$-5.87M
Operating margin—-59.53%
Net margin—-67.70%
52-week high$18.35$1.80
52-week low$0.68$0.1128
Distance from 52-week high-95.48%-93.61%
Analyst consensusholdnone
Avg. price target upside—+2508.70%
Average volume2.01M30.20M
Shares outstanding6.08M31.20M
Employees79713
SectorConsumer DiscretionaryConsumer Discretionary
IndustryBusiness ServicesBusiness Services

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Axonex AI Group

AXNX stock →

Axonics, Inc., a medical technology company, engages in the development and commercialization of novel products for the treatment of bladder and bowel dysfunction. Its sacral neuromodulation (SNM) systems are used to treat patients with overactive bladder (OAB), including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence (FI) and non-obstructive urinary retention (UR); and rechargeable (R20) and recharge-free (F15) implantable SNM systems that delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce the symptoms of OAB, UR, and FI.

Consumer Discretionary · Business Services · 797 employees

About OLB Group

OLB stock →

The OLB Group, Inc. provides integrated financial and transaction processing services for small and mid-sized merchants in the United States.

Consumer Discretionary · Business Services · 13 employees

AXNX vs OLB FAQ

Which is bigger, Axonex AI Group or OLB Group?

Axonex AI Group (AXNX) is larger, with a market capitalization of $5.28M compared with $3.59M for OLB Group (OLB).

Are Axonex AI Group and OLB Group in the same industry?

Yes. Both are classified in the Business Services industry within the Consumer Discretionary sector.

More comparisons